How This Works CJC-1295 DAC and Ipamorelin both target the growth-hormone (GH) axis, but through different mechanisms
This peptide inhibited TGF-1/Smad2/3 and STAT3 pathways, leading to decreased inflammation, tubular atrophy, myofibroblast activation, and fibrotic gene expression (Gwon et al., 2021)
Both are sterile and free of contaminants
In REDEFINE 1 (no diabetes), CagriSema produced an estimated mean weight change of about 20.4% at 68 weeks
Tamouza R, Volt F, Richard J-R, Wu C-L, Bouassida J, Boukouaci W, Lansiaux P, Cappelli B, Scigliuolo GM, Rafii H, Kenzey C, Mezouad E, Naamoune S, Chami L, Lejuste F, Farge D and Gluckman E (2022) Possible Effect of the use of Mesenchymal Stromal Cells in the Treatment of Autism Spectrum Disorders: A Review